Vaughn D Bryson insider trades: Atherogenics (AGIX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vaughn reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 8, 2008 | AGIX | ↑ Buy | 50,000 | $0.64 | $32K | Direct | Feb 11, 2008 (3d) |
| Jan 22, 2008 | AGIX | ↓ Sell | 3,386 | $0.39 | $1K | Direct | Feb 15, 2008 (24d) |
| Dec 28, 2007 | AGIX | ↓ Sell | 75,905 | $0.39 | $30K | Direct | Dec 31, 2007 (3d) |
| Dec 20, 2007 | AGIX | ↓ Sell | 7,657 | $0.43 | $3K | Direct | Dec 26, 2007 (6d) |
| Aug 29, 2007 | AGIX | ↓ Sell | 55,518 | $2.15 | $119K | Direct | Sep 5, 2007 (7d) |
| Jun 30, 2006 | AGIX | ↑ Buy | 40,000 | $13.01 | $520K | Direct | Jul 3, 2006 (3d) |
| May 30, 2006 | AGIX | ↑ Buy | 20,000 | $13.87 | $277K | Direct | May 31, 2006 (1d) |
| May 6, 2005 | AMLN | ↑ Buy | 20,000 | $16.71 | $334K | by Trust | May 9, 2005 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vaughn D Bryson's insider trades
Vaughn D Bryson is a director at Atherogenics (AGIX). Since May 6, 2005, Vaughn has reported 4 open-market purchases worth $1.2M and 4 sales worth $154K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), shares returned to the company (4 filings), option exercises (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.